American Well Corporation (AMWL) Stock Analysis & Winston Score
American Well, also known as Amwell, runs a telehealth platform that connects patients with doctors and other healthcare providers through video visits. Its main customers are health insurance companies, large hospital systems, and employers who use Amwell's software to offer virtual care to their members and employees. The company operates in the digital health industry and competes in the crowded U.S. telehealth market alongside companies like Teladoc. Amwell makes money by charging health systems and insurers licensing and subscription fees to use its platform, rather than billing patients directly. It operates mainly in the United States, with some international presence, and generates roughly $300 million in annual revenue. The company has not yet turned a profit, with significant operating losses each year, and its main challenge is reaching profitability while competing against well-funded rivals and navigating slower-than-expected adoption of telehealth services after the post-pandemic surge faded.
Winston Score: 16/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $13.23
Market Cap: $221M
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: New York Stock Exchange
